CB
Bourquin, Carole
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review | Non-coding RNA |  | 2024 | 80 | 8 | ||
| GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | Frontiers in immunology | | 2024 | 61 | 15 | ||
| Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer | Heliyon | | 2023 | 85 | 12 | ||
| Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells | Antioxidants | | 2023 | 168 | 24 | ||
| Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer | Oncoimmunology | | 2023 | 90 | 20 | ||
| PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo | ACS nano | | 2022 | 222 | 18 | ||
| Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles | Journal of controlled release | | 2022 | 286 | 144 | ||
| HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis | European Journal of Immunology | | 2021 | 135 | 47 | ||
| The interleukin-1 cytokine family members: role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy | Cytokine & growth factor reviews | | 2021 | 162 | 66 | ||
| Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice | ACS Nano | | 2021 | 294 | 423 | ||
| Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria | International Journal of Nanomedicine | | 2020 | 384 | 142 | ||
| Médiateurs de l'aspirine dans l'arsenal anticancéreux ? | Revue médicale suisse | | 2020 | 248 | 320 | ||
| Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes in vitro | ACS Nano | | 2019 | 349 | 336 | ||
| Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study | European Journal of Pharmaceutics and Biopharmaceutics | | 2019 | 442 | 384 | ||
| Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation | Biomaterials | | 2019 | 447 | 388 | ||
| CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes | Journal of Experimental Medicine | | 2019 | 392 | 280 | ||
| Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists | Pharmacological Research | | 2019 | 433 | 732 | ||
| Bionanomaterials for the Delivery of Cancer Immunotherapy | Chimia | | 2019 | 350 | 166 | ||
| Hook length of the bacterial flagellum is optimized for maximal stability of the flagellar bundle | PLOS Biology | | 2018 | 383 | 226 | ||
| Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation | International Journal of Pharmaceutics | | 2018 | 524 | 486 | ||
| Engineered hybrid spider silk particles as delivery system for peptide vaccines | Biomaterials | | 2018 | 392 | 335 | ||
| Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells | Nanomedicine | | 2017 | 439 | 379 | ||
| Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade | Oncoimmunology | | 2017 | 116 | 77 | ||
| NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response | Oncotarget | | 2017 | 379 | 150 | ||
| A rapid screening method to evaluate the impact of nanoparticles on macrophages | Nanoscale | | 2017 | 426 | 301 | ||
| Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses | Oncoimmunology | | 2016 | 132 | 48 | ||
| TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function | Oncoimmunology | | 2016 | 129 | 52 |
